Literature DB >> 7735941

Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time.

P Sipponen1, K Kimura.   

Abstract

BACKGROUND: The pathogenetic association of chronic atrophic gastritis and intestinal metaplasia with gastric cancer implies that the trends seen in these disorders over time should be similar. Both should similarly decrease in incidence with time, and a time-related relationship should occur between the incidence of gastric cancer and the rate of development of atrophic gastritis in the stomach of Helicobacter pylori-infected subjects. AIMS AND METHODS: We reviewed some recent studies from Finland on the time trends seen in chronic gastritis, atrophic gastritis (and intestinal metaplasia) and gastric cancer over a period of 15 years (1977-1992). In addition, using results from earlier studies from Japan and Finland, we formed hypotheses on how the time-dependent evolution and extension of atrophic gastritis may accord with the occurrence of gastric cancer in the stomach.
RESULTS: Our investigations showed that the incidence of gastric cancer and the prevalence of H. pylori-associated gastritis, atrophic gastritis and intestinal metaplasia have decreased similarly in outpatient series during the last 15 years. Correspondingly, gastric cancer, atrophic gastritis and intestinal metaplasia are cohort phenomena in the population, and the prevalence rate of atrophic gastritis is correlated with the cohort-specific incidence of gastric cancer; both are high in cohorts born near the beginning of the century but are quite low in those born in recent decades. Since antral and angular areas of the stomach are primary sites for gastric cancer tumours, the earlier investigations indicate that the time-dependent progression of gastritis in grade (development of atrophic gastritis and intestinal metaplasia) and extent (spreading of gastritis by pylorocardial extension) is well correlated with the rate and predisposition of gastric cancer tumours in the distal and angular stomach.
CONCLUSIONS: We conclude that atrophic gastritis (or intestinal metaplasia) and gastric cancer are very much alike in time trends and in course. This parallelism favours suggestions that H. pylori-associated gastritis with atrophic and metaplastic sequelae (atrophic gastritis) contribute to the pathogenesis of gastric cancer.

Entities:  

Mesh:

Year:  1994        PMID: 7735941

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  21 in total

1.  Association between Helicobacter pylori and gastric cancer: current knowledge and future research.

Authors:  Harry Hua-Xiang Xia
Journal:  World J Gastroenterol       Date:  1998-04-15       Impact factor: 5.742

2.  Gastrointestinal tract specific gene GDDR inhibits the progression of gastric cancer in a TFF1 dependent manner.

Authors:  Guanghui Chu; Shengbin Qi; Guodong Yang; Kefeng Dou; Jianjun Du; Zifan Lu
Journal:  Mol Cell Biochem       Date:  2011-08-26       Impact factor: 3.396

3.  AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa.

Authors:  Soichiro Kawata; Kazuo Yashima; Sohei Yamamoto; Shuji Sasaki; Yohei Takeda; Akihiro Hayashi; Kazuya Matsumoto; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

4.  Relationship between progression of gastric mucosal atrophy and Helicobacter pylori infection: retrospective long-term endoscopic follow-up study.

Authors:  N Sakaki; T Arakawa; H Katou; K Momma; N Egawa; T Kamisawa; Y Yamada; Y Tu; C Ishikawa; J Ishiwata
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

5.  Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.

Authors: 
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

6.  Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer.

Authors:  David S Jencks; Jason D Adam; Marie L Borum; Joyce M Koh; Sindu Stephen; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

7.  Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands.

Authors:  A C de Vries; G A Meijer; C W N Looman; M K Casparie; B E Hansen; N C T van Grieken; E J Kuipers
Journal:  Gut       Date:  2007-08-14       Impact factor: 23.059

8.  Transient and persistent Helicobacter pylori colonization in Native American children.

Authors:  Guillermo I Pérez-Pérez; R Bradley Sack; Raymond Reid; Mathuram Santosham; Janne Croll; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 9.  Gastric Cancer: an Evolving Disease.

Authors:  Minkyo Song; Charles S Rabkin; M Constanza Camargo
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

10.  Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia.

Authors:  Shahram Agah; Babak Shazad; Babak Abbaszadeh
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.